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The inflammatory caspase family of enzymes are 
invoked during the innate immune response, 
often as a consequence of pathogen associated 
molecular patterns (PAMPS) or damage 
associated molecular patterns (DAMPS).1 
Caspases respond to these stimuli by cleaving 
interluekin 1-𝛽 (IL-1 𝛽) and gasdermin D 
(GSDMD), amoung others, into their active form, 
generating the inflammatory cascade. When this 
inflammatory response is dysregulated, disease 
states such as sepsis, gout, and other 
autoinflammatory disorders can occur.2,3  
 
 
Caspase-1 activation has long been understood to 
incorporate the aggregation of nucleotide 
oligomerization domain (NOD-), leucine rich 
repeat (LRR) and pyrin domain-containing 
protein 3 (NLRP3), apoptosis-associated speck-
like protein containing a caspase activation and 
recruitment domain (ASC) and pro-caspase 1 to 
form the canonical NLRP3 inflammasome 
(Figure 1, left side). However, little is known 
regarding the caspase-4 activation pathway. 
Current studies suggest that caspase-4 activation 
 
ABSTRACT. Inflammatory caspases are involved in the innate immune response, in which cell 
damage and microorganism invasion lead to cell death via pyroptosis and the release of chemical signals 
that produce inflammation. Currently, little is known pertaining to the mechanism of activation for one 
of the major caspase isoforms, caspase-4, other than its ability to bind lipopolysaccharides (LPS) and 
become more active upon binding. It has been theorized that LPS promotes caspase-4 aggregation 
through a non-canonical pathway leading to its subsequent activation. Alternatively, caspase-4 may be 
activated after interacting with LPS micelles rather than monomeric units. Herein, we sought to 
incorporate LPS into previously optimized enzymatic assay conditions to potentially induce aggregation 
via direct binding or micelle formation as a scaffold. It was proposed that pro-caspase-4 zymogens 
would either bind LPS micelles to form a complex that would activate caspase-4 upon cleavage, or that 
activation could occur through the binding of monomeric LPS directly and oligomerization of caspase-
4. However, enzymatic assays performed with caspase-4 and various amounts of LPS showed no 
significant change in activity. The lack of change does not validate one mechanism of activation over 
the other, as both mechanisms are LPS dependent. Further studies of the activation mechanism and the 
presence of aggregates will be needed to determine the role of LPS in caspase-4 activation.  
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occurs through binding of gram negative 
lipopolysaccharide (LPS) to the caspase 
activation and recruitment (CARD)-domain of 
pro-caspase-4, stimulating oligomerization of the 
LPS-bound caspase-4.4 More recently, it has been 
theorized that pro-caspase-4 binds to large LPS 
micelles at its CARD domain followed by 
sequential proteolysis of the complex leading to 
active caspase-4.5 The exact oligomerization state 
and the overall structure of the combined 
complex is yet to be uncovered. This is due in part 
to the autoproteolytic activity of caspase-4, which 
makes the complex difficult to isolate. Previous 
experiments have been performed using 
mutagenically inactivated caspase-4 to 
ameliorate this issue, however this methodology 
does not provide an accurate representation of 
what occurs invivo. Herein, in vitro assay 
conditions were optimized in order to monitor 
caspase-4 activity with the incorporation of LPS. 
Variables examined included the concentration of 
caspase-4, incubation times, temperature, buffer 
components, and the addition of activating agents 
such as dithiothreitol (DTT). If LPS indeed 
activates caspase-4, increased activity is expected 
for upon addition of LPS within in vitro assays. 
For this reason, LPS titration studies were 
performed in order to understand its role in the 





Standard Fulorogenic Assay with Caspase-4 
 
All enzymatic assays were performed using the 
Biotek H1 Synergy 3000 Hybrid plate reader for 
fluorescence measurement. Wells contained 
caspase-4 (100 nM), the peptide-based substrate 
WEHD-AMC (20 𝜇M), where AMC is 7-amino-
4-methylcoumarin, and DTT (3 mM). Wells were 
supplemented with caspase buffer (50 mM 
HEPES, 50 mM NaCl, 0.1 % CHAPS, 10 mM 
 
Figure 1. Schematic of canonical and non-canonical pathways of inflammasome activation and subsequent 
steps leading to pyroptosis. 
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EDTA, 5 % glycerol, pH 7.2) to achieve a total 
volume of 100 μL. Kinetic data were obtained 
using previously determined fluorescence assay 
conditions for the fluorophore AMC linked to the 
substrate (excitation 380 nm, emission 460 nm).6 
Each experiment was run in triplicate for a 
duration of 90 minutes. Depending on the 
variables tested, a prior 30-minute incubation of 
caspase 4 with DTT was allotted in certain cases. 
Temperature was also manipulated in certain 
cases, in which samples were set to 37 °C during 
florescent monitoring. 
 
LPS Titration Assay with Caspase-4 
 
LPS titration assays were performed using similar 
methodology to that of the standard flourgenic 
assays with varrying LPS concentrations (0- 10 
μM). All wells were supplemented with caspase 
buffer to achieve a total volume of 100 μL each. 
Manipulated variables for this assay included 
varying incubation time (0, 10, 40 min) of LPS 
with caspase-4, the addition of heat (37 °C) in 
certain cases, and the addition of DTT (3 mM). 
CHAPS, from the caspase buffer used, was tested 
usingdynamic light scattering (DLS) for 
observation of micellular formation as a 
preventative measure to ensure it was not 
disrupting potential LPS micelle formation in 
solution.  DLS measurements were conducted  
 
using an Anton Paar LitesizerTM 100  
instrument. 
 
RESULTS & DISCUSSION  
 
The mechanism of activation for caspase-1 is 
characterized by the aggregation of inactive pro-
caspase-1 with NLRP3 and ASC following a 
PAMP or DAMP signal (Figure 1). The complex 
formed undergoes proteolysis to generate active 
caspase-1. The active enzyme can then cleave the 
inactive substrates, pro-interleukin-1𝛽 and 
GSDMD, into their respective active forms 
causing a potassium efflux and cell rupture. For 
caspase-4/5 the mechanism of activation is far 
less understood. It has been proposed that LPS-
rich outer-membrane vesicles of bacteria are 
endocytosed, after which they bind to the CARD 
domain of pro-caspase 4/5 in the cytosol.  
However, the complex formed and its mechanism 
of dissociation into active caspase-4 remains 
undetermined (Figure 1). What is known about 
this cellular process is that, similar to caspase-1, 
caspase-4 is able to cleave GSDMD into its active 
form (GSDM-N) causing the same down stream 







Figure 2. LPS Titration Progress Curve. Progress curves of caspase-4 with WEHD-AMC and LPS 
(Red: 0 μM LPS, Orange: 1 𝜇M LPS, Green: 2 𝜇M LPS, Blue: 5 𝜇M LPS, and Purple: 10 𝜇M LPS). 
Reactions were performed at 37 °C using the LPS titration assay protocol. 
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Despite the apparent need for LPS to function as 
a PAMP to induce high levels of caspase-4 
activity, this relationship was not observed 
through conducted in vitro enzymatic assays. To 
test the effect of LPS on the enzymatic activity of 
caspase-4, an LPS titration assay was performed 
(Figure 2). Through the obtained results, it is 
evident that despite the increasing concentration 
of LPS, the activity of caspase-4 did not change. 
Interestingly, samples that contained zero or low 
(1 𝜇M) LPS concentrations had slightly larger 
initial reaction velocities than that observed for 
the higher LPS concentrations (10 𝜇M). An initial 
justification for the observed trend was that 
caspase-4 requires LPS micelles to bind, and that 
their formation was being hinderd by pontential 
aggregation of the detergent CHAPS buffer 
component. To rule this out as a possibility, 
CHAPS was tested at varying percentages using 
DLS in an attempt to observe aggregates, 
however no aggregation was detected. LPS was 
also tested through DLS at its reported critical 
micelle concentration of 5 𝜇M.7 Interestingly, no 
micelle formation was detected through DLS for 
LPS.  It is not clear if this is an instrument 
sensitivity issue, or if micelles were truly absent.  
Additional work is needed to determine the 
degree to which LPS aggregates are present at 
these low concentrations.  
  
Based on the DLS results, the next justification 
for the trend observed in Figure 2 was the assay 
conditions being used for enzymatic testing, or 
that LPS requires a time dependent incubation 
with caspase-4 before the addition of substrate. 
Variables including addition of DTT, LPS 
incubation time, and incorporation of heat were 
manipulated to determine if they functioned as a 
potential limiting factor for LPS activation (Table 
1). LPS incubation with caspase-4 consisted of 0, 
10, or 40 minutes, while also manipulating the 
addition of DTT and its respective incubation 
time with caspase-4. As previously determined, 
DTT induced an increase in caspase-4 activity 
(trials 3 and 4), however, no conditions that 
incorporated LPS resulted inincreased enzymatic 
activity, as seen with trials 5-10 (Table 1).  
 
As none of the manipulated assay conditions 
allowed for LPS to induce higher levels of 
activity for caspase-4, other possible 
explanations to justify this rationale could 
simply be that the variant of LPS used is not 
compatible with the caspase CARD domain. 
Ostensibly, LPS is required to remain 
Table 1. Manipulated Assay Conditions for Caspase-4 and Their Effect on Kinetic Activitya 








1 - - - Control 
2 - - + Heat Control 
3 + (30 min) - + Increase 
4 + (none) - + Increase  
5 + (30 min) + (10 min) + No Change 
6 - + (10 min) + No Change 
7 + (30 min) + (40 min) + No Change 
8 + (none) + (none) + No Change 
9 + (none) + (none) + No Change 
10 + (none) + (none) + No Change 
aDTT and LPS concentrations were kept constant at 3 mM and 2 𝜇M, respectively, while incubation 
time with caspase-4 was varied for each. The substrate WEHD-AMC (20 𝜇M) was also incorporated for 
each reaction. When implemented, heat was maintained at 37 oC for the duration of fluorescence 
monitoring.  
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integrated within outer-membrane vesicles 
for pro-caspase-4 recognition. The future 
direction of our research is to incorporate 
new strains of LPS while also performing 
additional dynamic light scattering 
experiments at varying concentrations to 
observe possible LPS micelle formation. 
Further oligomerization studies will be 
performed on caspase-4 to determine the 
quantity of aggregates needed to form the 
possible non-canonical structure required for 
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